The BioCanRx network is changing the face of cancer treatment

 

BioCanRx’s vision is to cure patients and enhance the quality of life of those living with cancer. We will do this by supporting world-class research in the area of immune oncology, and by accelerating to the clinic the most promising cancer immunotherapies designed to save lives and enable a better quality of life. Through an innovative, collaborative funding process BioCanRx is becoming a world-leader in the translation, manufacture and adoption of leading edge cancer immunotherapy treatments for the benefit of cancer patients.

 

 

for-resesarchers-1
for-resesarchers-1
for-resesarchers-1
for-resesarchers-1

 

 

 


Ottawa Scientists Cure Aggressive Breast Cancer in Mice with Combination Therapy

 

A new Ottawa research study shows that “triple negative” breast cancer — a particularly aggressive form of the disease — can be successfully treated in mice with a combination of immunotherapies that weaponize the immune system in different ways.

 

Learn more →


BioCanRx’s 2016-2017 Annual Report is Now Available

 

Accelerating the Development of Promising Immunotherapies

 

Learn more →


Put Another Arrow in the Quiver

 

Of all the opponents in the battle against cancer, glioblastoma (GBM), an adult form of brain cancer, is among the worst.

 

Learn more →

 

 

Summit for Cancer Immunotherapy

BANFF, ALBERTA
summitforcancer
Join the BioCanRx Network at the 3rd annual Summit for Cancer Immunotherapy (Summit4CI) taking place in Banff!

October 27-30, 2018

Fairmont Banff Springs

View Cancer Summit

Sponsorship Opportunities
Learning Institute Community Dissemination Report 2017

The participants of the 2017 BioCanRx-Cancer Stakeholder Alliance Learning Institute wish to share their Community Dissemination Report with the oncology patient and researcher community, BioCanRx, the Cancer Stakeholder Alliance, and the general public.

Click here for the full report
For the latest BioCanRx news and network activities:

Subscribe to our newsletter and email updates Subscribe
Follow us on Twitter
Like us on Facebook
Follow us on Instagram Follow
Subscribe to us on Youtube  Subscribe
Follow us on LinkedIn Follow